Leukemia, a group of blood cancers that affect white blood cells, remains a significant global health concern. However, advancements in treatment options offer a glimmer of hope. The Leukemia Therapeutics Market, valued at USD 8,275.45 million in 2022, is projected to reach USD 13,491.42 million by 2030, reflecting a steady Compound Annual Growth Rate (CAGR) of 6.3% over the forecast period...